Bispecific Anti-her antibodies
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- F HOFFMANN LA ROCHE & CO AG
- Publication Date
- 2012-05-17
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
RELATED APPLICATIONS
[0001] This application claims the benefit of priority under 35 USC 119(e) of U.S. Provisional Application No. 61 / 210,562, filed Mar. 20, 2009, the disclosure of which is incorporated herein by reference in its entirety.FIELD OF THE INVENTION
[0002] The present invention concerns anti-HER antibodies, including multispecific anti-HER antibodies with binding specificity for at least two different HER receptors, and use of the antibodies to treat diseases or disorders.BACKGROUND OF THE INVENTION
[0003] The HER family of receptor tyrosine kinases are important mediators of cell growth, differentiation and survival. The receptor family includes four distinct members including epidermal growth factor receptor (EGFR, ErbB1, or HER1), HER2 (ErbB2 or p185neu), HER3 (ErbB3) and HER4 (ErbB4 or tyro2).
[0004] EGFR, encoded by the erbB1 gene, has been causally implicated in human malignancy. In particular, increased expression of EGFR has been observed in breast, bladder, lung, head...